??Our March issue is LIVE?? Learn about immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics in our cover profile???Sourcing, nurturing, and retaining talent ??Making HCP analytics actually work for commercial teams??and much more right here?? https://lnkd.in/eYxbJxsr
关于我们
Pharmaceutical Executive provides its audience of pharmaceutical and biopharmaceutical executives with the analysis of business, strategy, and government regulations. We go beyond the news and provide in-depth analysis to help executives navigate through the maze of policy and business challenges that face this industry. We do it through the review of the issues, interviews, and roundtable discussions with thought leaders and business leaders.
- 网站
-
https://www.pharmexec.com/
Pharmaceutical Executive的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Iselin，New Jersey
- 类型
- 私人持股
- 领域
- Publishing、Pharmaceutical News和Biopharmaceutical News
地点
-
主要
获取路线
US，New Jersey，Iselin，07072
Pharmaceutical Executive员工
动态
-
A huge thank you to Miranda Schmalfuhs and Pharmaceutical Executive for featuring Ian in this insightful episode! https://lnkd.in/dpxAf8my Instead of treating other voices as competition, pharmaceutical brands should partner with them to amplify credible, well-produced information. With 84% of social sharing happening through 1-to-1 links, providing trustworthy content to those acting as authorities can have a powerful impact. Listen to the full episode to learn more. https://lnkd.in/efUWbdDq soothbetold.com #InfluencerMarketing #CollaborationNotCompetition #CredibleContent #SocialSharing
-
Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize #UBT251 outside of China for #obesity and #type2diabetes for an upfront payment of $200 million. https://lnkd.in/e-wVGd9q
-
Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for #cardiovasculardisease, excluding Greater China. https://lnkd.in/e6rMtvmc
-
?? Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations surrounding #AI use in #medicationaccess and how the industry can ensure that these technologies are used responsibly and equitably. https://lnkd.in/esjxDtiH
-
#ICYMI: In the second part of her conversation with Pharmaceutical Executive, Kimberley Chiang, VP of biopharma commercial sales, leans into the actionable affordability strategies from the 2025 Medication Access Report, encouraging the industry to consider all dimensions of the patient journey. By using predictive analytics and balancing digital advancement with clinical expertise, we can help patients access and afford the medicine they need to live healthier lives. Read now: https://bit.ly/4iK05nh
-
Check out today's Pharma Pulse: https://lnkd.in/e9xm8u32
-
In this exclusive podcast, Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them. Listen to the podcast: https://lnkd.in/e8ibMrgd
-
Our founder and CEO Peter Ax recently shared valuable insights with Miranda Schmalfuhs from Pharmaceutical Executive on how #tariffs could reshape medication costs, availability, and patient access. Check out part 1 of their interview below to learn how #telehealth innovations are creating resilient medication delivery systems in an evolving economic landscape.
-
The potential vaccine is being developed in partnership with the Cleveland Clinic and the National Cancer Institute (NCI). USPTO Anixa Biosciences, Inc. #ovariancancer